Profile data is unavailable for this security.
About the company
Mabion SA is a Poland-based company primarily engaged in research and experimental development on natural sciences and engineering. The Company is the precursor of the biotechnology sector in Central Europe. The Company specializes in the production of sterile biotechnological products in a manufacturing plant that meets the requirements of Good Manufacturing Practice (GMP). The Company integrates and commercializes scientific achievements in order to develop a biological medicinal substance based on mammalian cell cultures. The Company participates in projects by combining scientific knowledge and advanced technology to develop products and processes. The Company provides its business partners with the biotechnological solutions and gives the patients access to the next generation of therapeutics.
- Revenue in PLN (TTM)139.86m
- Net income in PLN37.39m
- Incorporated2009
- Employees226.00
- LocationMabion SAgen. Mariana Langiewicza 60KONSTANTYNOW LODZKI 95-050PolandPOL
- Phone+48 422077890
- Fax+48 422032703
- Websitehttps://www.mabion.eu/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Read Gene SA | 11.63m | -1.00m | 69.09m | 11.00 | -- | 37.03 | -- | 5.94 | -0.1084 | -0.1084 | 1.16 | 0.1583 | 0.9731 | 51.32 | 18.69 | -- | -8.40 | -1.06 | -8.56 | -1.31 | 92.67 | 88.41 | -8.63 | -2.42 | 23.52 | -2.46 | 0.00 | -- | 40.14 | 16.00 | -731.53 | -- | -- | -- |
| Pure Biologics SA | 69.00k | -33.63m | 81.24m | 29.00 | -- | -- | -- | 1,177.38 | -10.40 | -10.40 | 0.0213 | -0.9246 | 0.0015 | -- | 0.2075 | 1,352.94 | -72.94 | -65.91 | -99.86 | -109.50 | -2,439.13 | 6.97 | -48,734.78 | -487.38 | -- | -8.41 | 1.30 | -- | -85.65 | -60.22 | -39.41 | -- | 1.65 | -- |
| Sds Optic SA | 370.00 | -8.98m | 82.87m | -- | -- | -- | -- | 223,982.30 | -1.52 | -1.52 | 0.00006 | -0.0545 | 0.00003 | 65.75 | 0.0006 | -- | -74.69 | -- | -86.32 | -- | -371,002.80 | -- | -2,452,795.00 | -- | 9.61 | -47.49 | -- | -- | -99.61 | -- | -85.09 | -- | -- | -- |
| Genomtec SA | -89.00k | -9.59m | 98.06m | -- | -- | 17.37 | -- | -- | -0.8159 | -0.8159 | -0.0076 | 0.4604 | -0.0064 | 27.93 | -- | -- | -68.62 | -- | -107.95 | -- | -- | -- | -- | -- | 1.12 | -58.91 | 0.2064 | -- | -97.50 | -- | 24.44 | -- | -- | -- |
| Nanogroup SA | -24.98k | -7.35m | 100.73m | -- | -- | 25.65 | -- | -- | -0.3477 | -0.3477 | -0.0012 | 0.1587 | -0.0016 | 7.38 | -- | -- | -47.32 | -23.18 | -59.79 | -26.06 | -- | -278.03 | -- | -1,567.57 | 0.4541 | -2,241.44 | 0.00 | -- | -98.55 | -55.07 | -840.84 | -- | -8.99 | -- |
| Urteste SA | 0.00 | -5.49m | 134.20m | -- | -- | 5.08 | -- | -- | -4.21 | -4.21 | 0.00 | 18.74 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 16.97 | -- | 0.0263 | -- | -100.00 | -- | -37.59 | -- | -- | -- |
| Molecure SA | 360.18k | -21.91m | 235.37m | 112.00 | -- | 2.50 | -- | 653.47 | -1.35 | -1.35 | 0.0223 | 5.59 | 0.003 | -- | 0.0741 | 3,244.87 | -18.17 | 2.64 | -19.29 | 2.76 | -444.01 | 97.54 | -6,082.40 | 12.84 | -- | -- | 0.0657 | -- | -18.85 | 237.24 | -19.67 | -- | -24.82 | -- |
| Poltreg SA | 600.00k | -17.42m | 254.62m | 23.00 | -- | 3.21 | -- | 424.37 | -3.74 | -3.74 | 0.1287 | 17.04 | 0.0051 | 27.12 | 3.22 | 26,373.63 | -14.82 | -6.51 | -16.41 | -7.35 | -1,804.83 | -391.38 | -2,903.50 | -449.24 | 4.21 | -- | 0.0913 | -- | 40.04 | -- | -588.92 | -- | 214.26 | -- |
| Mabion SA | 139.86m | 37.39m | 270.88m | 226.00 | 7.25 | 1.86 | 5.88 | 1.94 | 2.31 | 2.31 | 8.65 | 9.01 | 0.7538 | 4.02 | 17.35 | 618,836.30 | 20.15 | -7.19 | 25.09 | -16.79 | 78.30 | 58.10 | 26.73 | -14.27 | 1.64 | 101.63 | 0.026 | -- | -7.50 | -- | 77.94 | -- | 40.86 | -- |
| BIOTON SA | 186.32m | -6.85m | 290.22m | 358.00 | -- | 0.4849 | 11.26 | 1.56 | -0.0797 | -0.0797 | 2.17 | 6.97 | 0.2303 | 1.02 | 21.19 | 520,435.80 | -0.8464 | -1.99 | -1.04 | -2.47 | 33.80 | 45.33 | -3.67 | -8.61 | 0.2085 | 0.3295 | 0.0864 | -- | -22.10 | -5.51 | 60.10 | -38.69 | 0.3284 | -- |
| Captor Therapeutics SA | 18.64m | -46.69m | 345.98m | 104.00 | -- | 6.83 | -- | 18.56 | -10.29 | -10.29 | 4.08 | 10.87 | 0.2391 | -- | 5.26 | 179,230.80 | -59.88 | -- | -83.65 | -- | 51.97 | -- | -250.46 | -- | -- | -- | 0.1114 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
| Scope Fluidics SA | 93.00k | -22.60m | 447.05m | 40.00 | -- | 6.03 | -- | 4,807.02 | -8.29 | -8.29 | 0.0341 | 27.18 | 0.0009 | 2.94 | 0.0337 | 2,325.00 | -21.76 | 52.74 | -22.74 | 57.32 | -2,022.58 | -420.87 | -24,304.30 | 30,134.78 | 13.86 | -- | 0.0299 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
| Selvita SA | 337.26m | 65.30m | 1.15bn | 387.00 | 17.68 | 3.53 | 10.24 | 3.42 | 3.56 | 3.56 | 18.37 | 17.83 | 0.553 | 9.29 | 4.70 | 398,178.30 | 10.71 | -- | 12.99 | -- | 79.66 | -- | 19.36 | -- | 1.41 | 11.34 | 0.4063 | -- | -3.48 | -- | 130.55 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Mabion SA's reporting currency: Polish New Zloty PLN
3.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Generali PTE SAas of 29 Dec 2023 | 359.99k | 2.23% |
| Investors TFI SAas of 31 Dec 2023 | 197.37k | 1.22% |
| IPOPEMA TFI SAas of 30 Jun 2023 | 1.67k | 0.01% |
| SSgA Funds Management, Inc.as of 05 Sep 2024 | 260.00 | 0.00% |
| PKO TFI SAas of 31 Jul 2024 | 222.00 | 0.00% |
| Goldman Sachs Towarzystwo Funduszy Inwestycyjnych SAas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 29 Dec 2023 - 31 Jul 2024Source: FactSet Research Systems Inc.
